Detalhe da pesquisa
1.
Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry.
Ann Hematol
; 102(10): 2815-2822, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37474632
2.
Epidemiology of invasive fungal disease in haematologic patients.
Mycoses
; 64(3): 252-256, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33141969
3.
Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?
Mycoses
; 62(5): 413-417, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30720902
4.
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry.
Int J Cancer
; 142(5): 883-890, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29023692
5.
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry.
Hematol Oncol
; 36(1): 189-195, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28643458
6.
Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian Portuguese.
Hematol Transfus Cell Ther
; 44(3): 321-327, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-33483290
7.
Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis.
Blood Cells Mol Dis
; 60: 74-7, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26994960
8.
Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature.
Front Oncol
; 8: 32, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29515972
9.
Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53.
Stem Cell Res
; 33: 130-134, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30343103
10.
Treatment outcomes in classic Hodgkin lymphoma: 5-year update from the Brazilian Hodgkin Lymphoma Registry.
EJHaem
; 4(4): 1191-1195, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-38024602
11.
Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian Portuguese
Hematol., Transfus. Cell Ther. (Impr.)
; 44(3): 321-327, July-Sept. 2022. tab
Artigo
Inglês
| LILACS | ID: biblio-1405003
12.
Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition.
Front Oncol
; 7: 206, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28955657
13.
Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation.
Stem Cell Res
; 24: 16-20, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29034885
14.
Hydroxyurea dose impacts hematologic parameters in polycythemia vera and essential thrombocythemia but does not appreciably affect JAK2-V617F allele burden.
Haematologica
; 96(3): e18-20, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21357711
15.
Myelodysplastic syndrome without ring sideroblasts and with Janus kinase 2 gene mutation: An unusual case report.
Mol Clin Oncol
; 5(3): 227-230, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27588186
16.
Intensified ABVP chemotherapy for the primary treatment of Hodgkin's disease.
Oncol Rep
; 9(2): 439-42, 2002.
Artigo
Inglês
| MEDLINE | ID: mdl-11836623
17.
JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia.
Leuk Lymphoma
; 55(1): 128-35, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23607255
18.
Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
Rev Bras Hematol Hemoter
; 37(2): 142-3, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25818829
19.
Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
Rev. bras. hematol. hemoter
; 37(2): 142-143, Mar-Apr/2015. graf
Artigo
Inglês
| LILACS | ID: lil-746101
20.
Transplante de células-tronco hematopoéticas em gamopatias monoclonais / Hematopoietic stem cell transplantation for monoclonal gammopathies
Rev. bras. hematol. hemoter
; 32(supl.1): 115-124, maio 2010. tab, ilus
Artigo
Português
| LILACS | ID: lil-554158